When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...
Canada's health regulator has approved Merck's new under-the-skin version of its cancer drug Keytruda, offering an alternative to the current intravenous infusion. Health Canada has approved Keytruda ...
Merck , known as MSD outside of the United States and Canada, announced today that Health Canada has approved KEYTRUDA SCtm (pembrolizumab injection), a new subcutaneous formulation of pembrolizumab, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results